MCK vs VXRT · P/E 20, rev $403.43B vs rev $28.7M
McKesson Corporation (MCK) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the MCK and VXRT stock pages for the full models.
Not investment advice.